A carregar...
Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016
In response to the rising cost of cancer drugs, the National Comprehensive Cancer Network (NCCN) recently developed a value framework, known as “Evidence Blocks,” to grade the efficacy, safety, evidence quality, evidence consistency, and affordability of treatments included in its clinical guideline...
Na minha lista:
| Publicado no: | JNCI Cancer Spectr |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649801/ https://ncbi.nlm.nih.gov/pubmed/31360849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pky016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|